Article
Long-term anti-CD4 treatment of MRL/lpr mice ameliorates immunopathology and lymphoproliferation but fails to suppress rheumatoid factor production.
Clinical immunology and immunopathology - 1 Dec 1991
O'Sullivan F X, Ray C J, Takeda Y, Sharp G C, Walker S E
Abstract excerpt
MRL/lpr mice were treated with anti-CD4 mAb to define the role of CD4+ T cells in the pathogenesis of autoimmune disease and the lymphoproliferation characteristic of the strain. Anti-CD4 treatment was not associated with adverse effects, and survival of treated mice was increased over that of rat IgG-treated controls. Renal function was preserved, and the histologic severity of glomerulonephritis was minimal in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
